414 related articles for article (PubMed ID: 16420079)
1. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.
van Oppen P; van Balkom AJ; de Haan E; van Dyck R
J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.
van Balkom AJ; de Haan E; van Oppen P; Spinhoven P; Hoogduin KA; van Dyck R
J Nerv Ment Dis; 1998 Aug; 186(8):492-9. PubMed ID: 9717867
[TBL] [Abstract][Full Text] [Related]
3. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
[TBL] [Abstract][Full Text] [Related]
5. Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy.
van Balkom AJ; Emmelkamp PM; Eikelenboom M; Hoogendoorn AW; Smit JH; van Oppen P
Psychother Psychosom; 2012; 81(6):366-74. PubMed ID: 22964609
[TBL] [Abstract][Full Text] [Related]
6. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
7. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy.
de Haan E; van Oppen P; van Balkom AJ; Spinhoven P; Hoogduin KA; Van Dyck R
Acta Psychiatr Scand; 1997 Nov; 96(5):354-61. PubMed ID: 9395153
[TBL] [Abstract][Full Text] [Related]
8. Sudden gains in the treatment of obsessive-compulsive disorder.
Aderka IM; Anholt GE; van Balkom AJ; Smit JH; Hermesh H; van Oppen P
Psychother Psychosom; 2012; 81(1):44-51. PubMed ID: 22116471
[TBL] [Abstract][Full Text] [Related]
9. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
10. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
Ivarsson T; Jensen S; Højgaard DRMA; Hybel KA; Torp NC; Melin K; Nissen JB; Weidle B; Thomsen PH; Dahl K; Skarphedinsson G
J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):519-527. PubMed ID: 38070870
[TBL] [Abstract][Full Text] [Related]
11. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
12. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
Zheng H; Jia F; Han H; Wang S; Guo G; Quan D; Li G; Huang H
Eur Neuropsychopharmacol; 2019 Mar; 29(3):397-404. PubMed ID: 30595354
[TBL] [Abstract][Full Text] [Related]
13. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
Tolin DF; Maltby N; Diefenbach GJ; Hannan SE; Worhunsky P
J Clin Psychiatry; 2004 Jul; 65(7):922-31. PubMed ID: 15291681
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine.
Nakatani E; Nakagawa A; Nakao T; Yoshizato C; Nabeyama M; Kudo A; Isomura K; Kato N; Yoshioka K; Kawamoto M
Psychother Psychosom; 2005; 74(5):269-76. PubMed ID: 16088264
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.
Hembree EA; Riggs DS; Kozak MJ; Franklin ME; Foa EB
CNS Spectr; 2003 May; 8(5):363-71, 381. PubMed ID: 12766692
[TBL] [Abstract][Full Text] [Related]
16. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
Rector NA; Richter MA; Katz D; Leybman M
Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
[TBL] [Abstract][Full Text] [Related]
17. The impact of depression on the treatment of obsessive-compulsive disorder: results from a 5-year follow-up.
Anholt GE; Aderka IM; van Balkom AJ; Smit JH; Hermesh H; de Haan E; van Oppen P
J Affect Disord; 2011 Dec; 135(1-3):201-7. PubMed ID: 21889802
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
19. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder.
Matsunaga H; Hayashida K; Kiriike N; Nagata T; Stein DJ
CNS Spectr; 2010 Apr; 15(4):258-65. PubMed ID: 20414175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
